Beaconcure

Beaconcure, founded in 2016 and headquartered in the United States, is transforming the biopharmaceutical industry with its AI-powered platform, Verify. The company's slogan, "Empowering biometrics teams to lead the change in statistical analysis and reporting through AI innovation," encapsulates its mission to streamline clinical study analysis validation.

By enabling biopharmaceutical companies and CROs to automate and enhance validation workflows, Beaconcure is crucial for accelerating the delivery of safe, effective treatments. The company's innovative approach significantly reduces error rates and enhances efficiency, which is vital for maintaining data integrity in regulatory submissions.

In June 2023, Beaconcure raised $14 million in Series B funding from NewVale Capital. This investment underscores the confidence in Beaconcure's capacity for ongoing innovation and growth in leveraging AI for the biotechnology and healthcare industries.